← Back to Search
Assessment Of Chemotherapy-induced DNA Damage In Peripheral Blood Leukocytes Of Cancer Patients Using The Alkaline Comet Assay.
N. Kopjar, V. Garaj-Vrhovac, I. Milas
Published 2002 · Medicine
Download PDFAnalyze on Scholarcy
The alkaline comet assay was employed to assess the pre- and post-treatment levels of in vivo DNA damage in peripheral blood leukocytes of cancer patients. During the study all patients were given antineoplastic drugs, mainly as polychemotherapy. To quantify the DNA damage, two different comet parameters were evaluated: the tail length and the tail moment. Our results indicate marked interindividual variations between baseline DNA damage in peripheral blood leukocytes recorded among cancer patients prior to the chemotherapy. After intravenous administration of various antineoplastic drugs, a significantly increased level of DNA damage in all cancer patients compared to their pre-treatment values was recorded The highest level of DNA damage was seen following administration of 5-fluorouracil, adriamycin, and cisplatin (FAP protocol). The results indicate that administration of antineoplastic drugs in standard protocols is accompanied by significant DNA damage in peripheral blood leukocytes. In order to diminish the potential risks of developing second neoplasms, a continuous biomonitoring of cancer patients after the ending of chemotherapy becomes important. Despite their limitations, present results confirm the usefulness of the alkaline comet assay as a sensitive biomarker of exposure that enables rapid and simple detection of primary DNA damage in peripheral blood leukocytes of cancer patients. Together with standard cytogenetic endpoints, the comet assay provides a powerful technique for the routine detection of critical DNA lesions produced after administration of antineoplastic drugs in the clinical settings.
This paper references
Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
E. Diamandidou (1996)
Application of biological markers in cancer environmental epidemiology.
B. Trock (1995)
Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999.
R. Sram (2000)
The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis?
A. Eastman (1992)
Induction of apoptosis by bleomycin in resting and cycling human lymphocytes.
P. Vernole (1998)
Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalan
S. Hansel (1997)
Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay.
P. Jałoszyński (1997)
Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies
C. Kollmannsberger (1998)
Application of the alkaline comet assay in human biomonitoring for genotoxicity: a study on Croatian medical personnel handling antineoplastic drugs.
N. Kopjar (2001)
Monitoring occupational exposure to cancer chemotherapy drugs.
E. S. Baker (1996)
Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.
A. Rothfuss (2000)
Microgel electrophoresis assay (comet test) and SCE analysis in human lymphocytes from 100 normal subjects.
C. Betti (1994)
Significance of lymphocytic sister chromatid exchange frequencies in ovarian cancer patients.
P. Dhar (1996)
Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay.
P. Fortini (1996)
Lack of adverse effect of smoking habit on DNA strand breakage and base damage, as revealed by the alkaline comet assay.
M. Wojewódzka (1999)
Considerations for population monitoring using cytogenetic techniques
A. Carrano (1988)
Problems in the estimation of mutation rates and in the detection of induced mutations in man.
I. Barrai (1975)
The comet assay in clinical practice.
P. L. Olive (1999)
Common fragile site expression and genetic predisposition to breast cancer.
G. Çeçener (1998)
Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.
M. Smith (1999)
Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks.
D. Anderson (1995)
The concepts of tail moment and tail inertia in the single cell gel electrophoresis assay.
B. Hellman (1995)
Cytogenetic studies in lymphocytes of patients with rectal cancer.
E. Gebhart (1993)
The comet assay: a comprehensive review.
D. Fairbairn (1995)
Chemistry of drug-induced DNA lesions
Saito Isao (1993)
Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro.
M. Dabholkar (1992)
Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing
R. Tice (2000)
DNA damage and repair in individual cells: applications of the comet assay in radiobiology.
P. L. Olive (1999)
Consequences of the resistance to drug-induced topoisomerase II-mediated DNA cleavage.
L. Zwelling (1993)
A simple technique for quantitation of low levels of DNA damage in individual cells.
N. Singh (1988)
Human effect monitoring in cases of occupational exposure to antineoplastic drugs: a method comparison.
S. Kevekordes (1998)
Application of cytogenetic endpoints and Comet assay on human lymphocytes treated with vincristine in vitro.
N. Kopjar (2000)
Synergism and antagonism in cancer chemotherapy
J. Patel (1992)
Pesticide-induced primary DNA damage in peripheral blood leukocytes of farm workers evaluated by the computerized 'comet' assay.
M. Moretti (2000)
Evaluation of the Porphyrinogenic Risk of Antineoplastics
Adriana Cristina Cochón (1997)
Second malignant neoplasms occuring in survivors of osteosarcoma
C. Pratt (1997)
Single cell gel electrophoresis assay: sensitivity of peripheral white blood cells in human population studies.
R. Sram (1998)
Sizing highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent.
P. L. Olive (1995)
Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide.
J. F. Haas (1987)
Alkaline single-cell gel electrophoresis and human biomonitoring for genotoxicity: a pilot study on breast cancer patients undergoing chemotherapy including cyclophosphamide.
H. Vaghef (1997)
High-dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay.
R. Tice (1992)
Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. II. Alteration of DNA repair and chromosome radiosensitivity.
O. Rigaud (1990)
Mutagenesis after cancer therapy.
K. Kelsey (1993)
Comet assay in human biomonitoring studies: Reliability, validation, and applications
A. Collins (1997)
Comet assay for nuclear DNA damage.
S. Piperakis (1999)
Alkaline single cell gel electrophoresis of DNA fragments in biomonitoring for genotoxicity: an introductory study on healthy human volunteers
B. Hellman (1997)
Analysis of chromate-induced DNA-protein crosslinks with the comet assay.
O. Merk (2000)
Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: correlations with the formation of DNA double-strand breaks.
E. Noviello (1994)
Detection of DNA lesions induced by chemical mutagens by the single cell gel electrophoresis (Comet) assay. 1. Relationship between the onset of DNA damage and the characteristics of mutagens.
Y. Miyamae (1997)
Melphalan may be a more potent leukemogen than cyclophosphamide.
M. Greene (1986)
DNA‐damaging effect of cyclophosphamide on human blood cells in vivo and in vitro studied with the single‐cell gel test (comet assay)
A. Hartmann (1995)
In vivo mutations in human blood cells: biomarkers for molecular epidemiology.
R. Albertini (1993)
This paper is referenced by
In vivo detection of DNA adducts induced by cisplatin using capillary HPLC–ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster
D. García Sar (2008)
Tumor Growth Inhibitory Effect of Juglone and Its Radiation Sensitizing Potential
K. Aithal (2012)
Measuring the genetic damage in cancer patients during radiotherapy with three genetic end-points.
Lou Jian-lin (2004)
[Biomonitoring of nurses occupationally exposed to antineoplastic drugs: the IMEPA Project].
C. Bolognesi (2005)
Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells
N. Kopjar (2006)
INCIDENCE AND RISK FACTORS OF MOST PREVALENT CANCERS IN INDIA
Bakhya Shree (2015)
Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells
Kiran B. Aithal (2009)
The heterocyclic ruthenium(III) complex KP1019 (FFC14A) causes DNA damage and oxidative stress in colorectal tumor cells.
S. Kapitza (2005)
Relationship between genotoxic effects of breast cancer treatments and patient basal DNA integrity.
M. Ceballos (2014)
Application of human lymphocytes for evaluating toxicity of anti-cancer drugs.
G. Suman (2006)
Evaluation of DNA damage in vivo induced by combined application of cisplatin and sevoflurane
G. Brozović (2008)
DNA damage induced by paclitaxel and DNA repair capability of peripheral blood lymphocytes as evaluated by the alkaline comet assay.
M. T. Branham (2004)
Avaliação in vitro da cisplatina, em linfócitos de pacientes com melanoma cutâneo, por meio de testes citogenéticos
F. Shimabukuro (2010)
Variation of ATM protein expression in response to irradiation of lymphocytes in lung cancer patients and controls.
Lou Jian-lin (2006)
Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factor.
E. Uriol (2013)
DNA damage in blood cells in relation to chemotherapy and nutritional status in colorectal cancer patients-A pilot study.
A. S. Kværner (2018)
Transplatin is cytotoxic when photoactivated: enhanced formation of DNA cross-links.
Pavla Heringová (2006)
Association between heat-shock protein 70 gene polymorphisms and DNA damage in peripheral blood lymphocytes among coke-oven workers.
X. Yang (2008)
Selenium as a Modulator of Efficacy and Toxicity of Chemotherapy and Radiation
Richard Lobb (2011)
DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer.
P. Sánchez-Suárez (2008)
Synthesis and antitumor activity of optically active thiourea and their 2-aminobenzothiazole derivatives: a novel class of anticancer agents.
S. Manjula (2009)
[Use of comet assay for the risk assessment of oil- and chemical-industry workers].
János Megyesi (2014)
Cytogenetic Studies on Leukocytes of Head and Neck Cancer Patients Undergoing Radiotherapy
S. B. Kadam (2014)
Antitumor, Immunomodulatory and Antiangiogenic Efficacy of Medicinal Mushroom Extract Mixtures in Advanced Colorectal Cancer Animal Model
Boris Jakopović (2020)
DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy.
S. Nadin (2006)
Potential use of the comet assay in the clinical management of cancer.
D. McKenna (2008)
DNA damage in peripheral lymphocytes of untreated breast cancer patients.
P. Sanchez (2004)
Mutant Nbs1 Enhances Cisplatin-Induced DNA Damage and Cytotoxicity in Head and Neck Cancer
H. M. Tran (2004)
Prediction of individual response to anticancer therapy: historical and future perspectives
F. T. Unger (2014)
Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules
K. Sankhala (2018)
Changes in the levels of comet parameters before and after fluoxetine therapy in major depression patients
Rajeev Panwar (2020)
Cytogenetic Analysis on the Yields of Chromosomal Aberrations Induced by the Scattered Doses of ÃÂ³-Radiation
Samit B Kadam (2016)See more